Eversept Partners, LP 908 Devices Inc. Transaction History

Eversept Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2023	SELL	$15.18 - $24.99 $5.16 Million - $8.49 Million	-339,676 Reduced 72.2%	130,768 $2.15 Million
Q3 2022 Nov 14, 2022	SELL	$15.18 - $24.99 $5.16 Million - $8.49 Million	-339,676 Reduced 72.2%	130,768 $2.15 Million
Q2 2022 Nov 08, 2023	BUY	$13.3 - $20.74 $3.37 Million - $5.25 Million	253,295 Added 116.65%	470,444 $9.69 Million
Q2 2022 Aug 15, 2022	BUY	$13.3 - $20.74 $3.37 Million - $5.25 Million	253,295 Added 116.65%	470,444 $9.69 Million
Q1 2022 Nov 08, 2023	BUY	$13.18 - $26.28 $2.86 Million - $5.71 Million	217,149 New	217,149 $4.13 Million
Q1 2022 May 16, 2022	BUY	$13.18 - $26.28 $2.86 Million - $5.71 Million	217,149 New	217,149 $4.13 Million

18.4M

14.1K

22K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $61.3M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.